Results 1 to 10 of about 26,979 (243)
Neuropsychopharmacology Reports, 2021 Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or abuse, and little attention has been paid to patients who are prescribed
Masahiro Takeshima, Kazuo Mishima
exaly +2 more sources
Saudi Pharmaceutical Journal, 2023 Background: The Saudi Food and Drug Authority (SFDA) classified pregabalin as a controlled substance in 2018; however, whether this policy change has affected pregabalin use is unclear.
Ahmed Al-jedai +6 more
doaj +1 more source
BMJ Open, 2022 Objectives The objectives of this study were to investigate the utilisation patterns of pregabalin, to identify users potentially misusing pregabalin and to compare this group of patients to patients prescribed recommended doses of pregabalin concerning ...
Ronja Flemming
doaj +1 more source
Pregabalin abuse: a case report
Psychiatry and Clinical Psychopharmacology, 2021 Pregabalin is a gamma-amino butyric acid (GABA) analogue used in the treatment of epilepsy, neuropathic pain, and generalized anxiety disorder. Although pregabalin is not a controlled medication in Turkey, it has a potential risk of abuse.
Ilhan Yargic, Filiz Alyanak Ozdemiroglu
doaj +1 more source
PREGABALIN EFFECTS ON CELLULAR AND HUMORAL COMPONENTS OF BLOOD OF MICE (Mus musculus) [PDF]
Basrah Journal of Veterinary Research, 2017 The oral use of pregabalin was evaluated in this study to reveal its effects on some hematological and biochemical parameters of laboratory mice. The animals of this study were divided into three groups (twelve mice each).
Wissam Sajid Hashim Al-Uboody
doaj +1 more source
Pregabalin addiction caracteristics at oran: A cohort study
European Psychiatry, 2021 Introduction Pregabalin is an analogue of gamma-aminobutyric acid (GABA). Recent reports suggest illicit pregabalin use may be increasing among youth, however its addictive potential has not been well established (1). Objectives Drug seeking behavior
C. Yasmine, D. Aicha
doaj +1 more source
9-PREGABALIN EFFECTS ON CELLULAR AND HUMORAL COMPONENTS OF BLOOD OF MICE (Mus musculus) [PDF]
Basrah Journal of Veterinary Research, 2018 The oral use of pregabalin was evaluated in this study to reveal its effects on some hematological and biochemical parameters of laboratory mice. The animals of this study were divided into three groups (twelve mice each).
Wissam Sajid Hashim Al-Uboody
doaj +1 more source
F1000Research, 2023 Background: Treatment of neuropathic pain is challenging. Pregabalin and duloxetine are used as first-line therapy. Various international guidelines recommend a combination of first-line agents for the management of neuropathic pain.
Sunil Dutt +8 more
doaj +1 more source
Pakistan Armed Forces Medical Journal, 2021 Objective: To assess the role of pregabalin as premedication for preoperative sedation & anxiolysis with two different doses in laparoscopic cholecystectomy patients.
Ayman Zafar +5 more
doaj +3 more sources
Renal Replacement Therapy, 2022 Background Severe pregabalin intoxication may cause serious symptoms, such as coma. Since pregabalin is a small molecule with no protein binding sites and has low volume of distribution, hemodialysis can be effective in eliminating pregabalin from the ...
Takashi Shimazui +8 more
doaj +1 more source